Journal of Cancer Science and Clinical Oncology

Editorial Board Member - JCS

Rodrigo Fernandez Valdivia

Assistant Professor
Department of Pathology
Wayne State University School of Medicine
United States

Dr. Rodrigo Fernandez- Valdivia graduated from Universidad Nacional de San Agustín (Arequipa, Peru) and he earned his Doctoral degree from Universidad Autónoma de Madrid, Spain. He was a graduate fellow from the Inter- University Council of the Belgium’s Francophone Community, the FISS program in Spain, and completed his postdoctoral fellowship in the Institute of Molecular Medicine at the University of Texas-Houston.

Dr. Fernandez- Valdivia’s contributions include the deciphering of the progesterone-regulated mammary gland transcriptome, the identification of ID4 and RANKL as direct progesterone receptor targets in the breast, the demonstration of the proliferative and carcinogenic properties of RANKL, the discovering Rumi—the sole enzyme capable of adding glucose molecules to proteins in mammals—and its regulatory role in Notch signaling pathway, and the generation of several genetically-engineered animal models to study breast development and tumorigenesis. Furthermore, he has developed the innovative transgenic and genetic engineering technologies with direct clinical impact. His work has been widely recognized, and he has been selected recipient of merit Awards from several scientific societies, scientific journals, biotechnological companies, the American Cancer Society, the Federation of American Societies for Experimental Biology (FASEB), and the NIH.

Dr. Fernandez-Valdivia is currently an Assistant Professor in the Departments of Pathology and Oncology at Wayne State University School of Medicine, and a Scientific Member of the Tumor & Microenvironment Program at the Barbara Ann Karmanos Cancer Institute. He is currently using his expertise in genetic engineering and mouse genetics to identify pharmacologically targetable pathways to treat breast cancer. His research program focuses on the role of O-linked glucose on the regulation of Notch signaling in breast development and carcinogenesis, with particular emphasis in mammary gland stem cells.

  • Breast cancer
  • Mammary gland development
  • Notch signaling
  • Steroid hormone signaling

Other Editorial Board Members - JCS

Suling Liu

School of Life Sciences
University of Science & Technology

Lili Chen

Associate Professor
Department of Radiation Oncology
Fox Chase Cancer Center
United States

Nagendra K. Prasad

Assistant Professor
Division of Hematology and Oncology
Indiana University School of Medicine
United States

Markus Müschen

Department of Laboratory Medicine
University of California, San Francisco
United States

Huafeng Zhang

School of Life Science
University of Science & Technology of China

Peter Lobie

Principal Investigator
Cancer Science Institute of Singapore
National University of Singapore

Zeina Ghorab

Assistant Professor
Department of Pathology
Sunnybrook Health Sciences Centre

Gary Lee Francis

Division of Endocrinology and Metabolism
Medical College of Virginia
United States

Ming Tan

Associate Professor
Mitchell Cancer Institute
United States

Dagmara McGuinness

Research Associate
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Submit Manuscript

Open Access Journals

View All Journals